Clinical Trials Directory

Trials / Unknown

UnknownNCT03741153

Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus

The Possible Association Between Pseudoexfoliation Syndrome and Diabetes Mellitus in an Egyptian Population

Status
Unknown
Phase
Study type
Observational
Enrollment
100 (estimated)
Sponsor
Assiut University · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

Pseudoexfoliation syndrome (PEX) is characterized by the deposition of a distinctive fibrillar material in the anterior segment of the eye and was first described in 1917 by Lindberg. It is frequently associated with open angle glaucoma, known as pseudoexfoliation glaucoma, which is one of the most common identifiable forms of secondary open angle glaucoma worldwide. Despite extensive research, the exactchemical nature of the fibrillar material is unknown. It is believed to be secreted multifocally in the iris pigment epithelium, the ciliary epithelium, and the peripheral anterior lens epithelium.

Conditions

Interventions

TypeNameDescription
DEVICEslit lamp1. Presence of white grayish exfoliation material on the anterior lens capsule and / or the pupillary margin. 2. Poor pupillary dilatation due to atrophy of the dilator pupillae muscle. 3. The presence of pseudoexfoliative material (PXF)in cilliary processes and zonules. 4. presence of PXF material scattered on corneal endothelium. 5. Flecks of the exfoliative material on the anterior chamber which leads to glaucoma.

Timeline

Start date
2019-01-01
Primary completion
2020-12-01
Completion
2021-03-14
First posted
2018-11-14
Last updated
2018-11-14

Source: ClinicalTrials.gov record NCT03741153. Inclusion in this directory is not an endorsement.